Nerve Block Treatment for Chronic Jaw Pain
Treatment of Chronic Temporomandibular Pain With Peripheral Nerve Block
1 other identifier
observational
40
1 country
1
Brief Summary
Study Summary: Nerve Block Treatment for Chronic Jaw Pain This study is being conducted at the TMJ (temporomandibular joint) clinic, which is part of the oral and maxillofacial surgery department. The goal is to evaluate how effective peripheral nerve blocks are in reducing long-term jaw pain in patients with chronic temporomandibular disorders (TMD) who haven't responded to at least two other types of treatment (such as physical therapy, medication, or bite splints). What Is the Treatment? Peripheral nerve blocks are injections that temporarily block nerve signals from the painful area. This can relieve pain and improve function. These blocks are already used routinely at the clinic. Who Can Join? Adults who have had jaw joint pain for over a year. Have tried at least two other treatments without success. Are mentally competent and not pregnant. What Will Participation Involve? You'll receive the nerve block treatment as part of your regular care. You'll be asked to attend follow-up visits, typically one every 4 months (3 per year). You'll be monitored for pain relief, mouth opening ability, and use of pain medications. You can stop participating at any time without affecting your care. How Will Data Be Handled? Your information will be stored securely and coded to protect your identity. Only the research team will have access to your personal information. How Many People Will Be in the Study? The goal is to recruit 40 patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 25, 2025
CompletedFirst Submitted
Initial submission to the registry
May 4, 2025
CompletedFirst Posted
Study publicly available on registry
May 12, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2026
ExpectedJune 10, 2025
April 1, 2025
1 year
May 4, 2025
June 9, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
VAS pain intensity
Pain intensity will be assessed using the Visual Analog Scale (VAS), ranging from 0 (no pain) to 10 (worst pain imaginable), before and after treatment.
One year
Secondary Outcomes (2)
Mouth opening meausurement
One year
Change in analgesic use
One year
Eligibility Criteria
Adult patients with chronic temporomandibular joint (TMJ) pain who attend the TMJ clinic at Beni Zion hospital, part of the Department of Oral and Maxillofacial Surgery. Participants are individuals who have experienced TMJ-related pain for at least one year and have not responded adequately to at least two prior treatment modalities (e.g., physiotherapy, medications, splints, or alternative therapies). Eligible patients will be those for whom a peripheral nerve block has been selected as part of their clinical care.
You may qualify if:
- Adults (non-pregnant) with sound judgment
- Chronic TMJ pain lasting at least 12 months
- Documented failure of at least two previous treatment modalities
You may not qualify if:
- Missing at least two follow-up visits within the specified timeframe
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Oral and Maxillofacial Surgery
Haifa, North, 3199500, Israel
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 4, 2025
First Posted
May 12, 2025
Study Start
April 25, 2025
Primary Completion
May 1, 2026
Study Completion (Estimated)
July 1, 2026
Last Updated
June 10, 2025
Record last verified: 2025-04